In Focus

Gyros raises SEK 80 million to accelerate the commercialization of its Gyrolab systems...

 [more]

Video highlights of

‘The 3rd Gyrolab Seminars 2009’ 

A wealth of practical experience featuring the most up-to-date, real-life applications from Gyrolab users.

Click here to get insights into the latest developments, and find out why there is so much buzz around Gyrolab

 [more]

MedImmune completes purchase of fifth Gyrolab system to further expand therapeutic antibody development...

 [more]
Events

BioProcess International

Raleigh Convention Center, Raleigh, NC, USA, 12-16 October 2009 [more]
Accelerate your development of therapeutic proteins
Gyros is the world leader in automated
micro-immunoassays for therapeutic protein development.
• Optimize immunoassays within days
• Permits four-log dynamic range with less matrix
or hook effects
• Enables assay designs free from multiplexing ambiguity
• Uses only nanoliters of precious sample and reagents